Earnings$BIIB6:05 AM ET3 wires · v3

Biogen Q3 revenue $2.8B, adjusted EPS $2.62; lifts FY guidance

By BORSA NewsroomPublished Oct 28, 2026, 6:05 AM EDTUpdated Oct 28, 2026, 6:06 AM EDT

Biogen reported Q3 revenue of $2.8 billion, up 11% year-over-year, and Non-GAAP EPS of $2.62. GAAP EPS was $(0.14) due to $284 million in transaction-related charges. The company raised the low end of full-year Non-GAAP EPS guidance to $12.20-$13.00.

Sentimentbullish 70

Bullish · 70 of 100

Impact70

medium · sector-wide

Confidence95%

high confidence · 3 wires

Eventconfirmed

v3 · alerted to followers

WHAT WE KNOW

Q3 total revenue $2.8B, up 11% YoY.
Non-GAAP diluted EPS $2.62.